| Role |
Name |
Disclosure |
Details |
| Author | Srinivas R Nalamachu, MD, Clinical Assistant Professor, Department of Internal Medicine, Kansas City University of Medicine and Biosciences; President and Medical Director, Internation Clinical Research Institute, Inc; Medical Director, Pain Management Institute | Nothing to disclose | Details | | Coauthor | Shireesha Nalamasu, MD, Consulting Staff, Methodist Hospital, Indianapolis; Hospitalist, Respiratory and Critical Care Consultants, PC | Nothing to disclose | Details | | Medical Editor | Robert J Kaplan, MD, Associate Professor, Department of Physical Medicine and Rehabilitation, University of Kansas School of Medicine and Medical Center | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Richard Salcido, MD, Chairman, Erdman Professor of Rehabilitation, Department of Physical Medicine and Rehabilitation, University of Pennsylvania School of Medicine | Nothing to disclose | Details | | CME Editor | Kelly L Allen, MD, Regional Medical Director, IMX-Medical Management Services | Nothing to disclose | Details | | Chief Editor | Denise I Campagnolo, MD, MS, Director of Multiple Sclerosis Clinical Research and Staff Physiatrist, Barrow Neurology Clinics, St. Joseph's Hospital and Medical Center; Investigator for Barrow Neurology Clinics; Director, NARCOMS Project for Consortium of MS Centers, Phoenix | Teva Neuroscience Serono-Pfizer | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Richard Salcido, Managing Editor |
The contributor discloses no conflict of interest. |
|